How does one ‘define value’ when considering a new technology? How does one create value when building a company on a novel platform? In today’s market, how does one price innovation in different healthcare systems?
Join us for the 12th annual Business of Regenerative Medicine conference, where distinguished speakers will provide insights — as well as guardrails — for navigating the emerging industry of regenerative medicine.
Engage with CEOs, venture capitalists, experts in biomedical research, and patient advocates to explore how advances in cell and gene therapy, drug development, and bioengineerng in regenerative medicine are moving from the lab to the patient — and what it will take to identify real, lasting value for business and society.